Back to Search
Start Over
FRI101 - The first double-blind randomized placebo-controlled phase 2 study to assess the efficacy and safety of insulin sensitizer in patients with non-alcoholic steatohepatitis in Asia-an interim report.
- Source :
-
Journal of Hepatology . 2020 Supplement 1, Vol. 73, pS449-S449. 1p. - Publication Year :
- 2020
- Subjects :
- *FATTY liver
*INSULIN
*HYPOGLYCEMIC agents
*NON-alcoholic fatty liver disease
Subjects
Details
- Language :
- English
- ISSN :
- 01688278
- Volume :
- 73
- Database :
- Academic Search Index
- Journal :
- Journal of Hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 145884619
- Full Text :
- https://doi.org/10.1016/S0168-8278(20)31379-9